CTSB and pancreatic neoplasm: Enzymatic activity for cathepsin B was significantly downregulated for all 3 disease groups (localized, metastatic, and pancreatitis) compared to the healthy control group, which indicated that cathepsin B can successfully detect both pancreatic cancer and pancreatitis.